World's Best Scientists 2026 revealed!
Xenofon Baraliakos

Xenofon Baraliakos

D-Index & Metrics

Medicine

D-Index
85
Citations
34986
World Ranking
14421
National Ranking
764

Overview

Xenofon Baraliakos is affiliated with Ruhr University Bochum in Germany and specializes in the field of Medicine, with a primary focus on Rheumatology. Their scholarly work spans several subfields, including Immunology, Hematology, Orthopedics and Sports Medicine, and Pathology and Forensic Medicine.

The scientist's research covers various topics within rheumatologic and autoimmune disorders. These main topics include:

  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Bone and Joint Diseases
  • Spine and Intervertebral Disc Pathology
  • Fibromyalgia and Chronic Fatigue Syndrome Research

Baraliakos has contributed extensively to academic literature, particularly in the journal Annals of the Rheumatic Diseases, with 182 publications. Additional frequent publication venues include:

  • Lara D. Veeken
  • RMD Open
  • Zeitschrift für Rheumatologie
  • Revue du Rhumatisme

Frequent collaborators of Baraliakos include:

  • Jürgen Braun
  • Uta Kiltz
  • Désirée van der Heijde
  • Denis Poddubnyy
  • David Kiefer

Among notable publications authored or co-authored by Baraliakos are:

  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update" (2020), published in Annals of the Rheumatic Diseases
  • "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" (2022), published in Annals of the Rheumatic Diseases
  • "Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement" (2020), published in Annals of the Rheumatic Diseases
  • "EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update" (2024), published in Annals of the Rheumatic Diseases
  • "Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study" (2021), published in Annals of the Rheumatic Diseases

Best Publications

  • The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis

    J. Sieper;M. Rudwaleit;X. Baraliakos;J. Brandt

  • 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Désirée van der Heijde;Sofia Ramiro;Robert Landewé;Xenofon Baraliakos

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

    Dominique Baeten;Joachim Sieper;Jürgen Braun;Xenofon Baraliakos

  • Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

    M. Rudwaleit;A. G. Jurik;K.-G. A. Hermann;R. Landewé

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

    Martin Rudwaleit;Hildrun Haibel;Xenofon Baraliakos;Joachim Listing

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

    Dominique Baeten;Xenofon Baraliakos;Jürgen Braun;Joachim Sieper

  • EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

    P Mandl;V Navarro-Compán;L Terslev;P Aegerter

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

    Désirée van der Heijde;Robert Landewé;Xenofon Baraliakos;Harry Houben

  • Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

    J. Braun;X. Baraliakos;W. Golder;J. Brandt

  • Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    J. Braun;X. Baraliakos;J. Listing;J. Sieper

  • Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

    Robert G W Lambert;Pauline A C Bakker;Désirée van der Heijde;Ulrich Weber

  • 2010 Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Braun;R. Van Den Berg;X. Baraliakos;H. Boehm

  • Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

    Uta Kiltz;Xenofon Baraliakos;Pantelis Karakostas;Manfred Igelmann

  • Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

    Heiner Appel;Gisela Ruiz-Heiland;Joachim Listing;Jochen Zwerina

  • Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab.

    Xenofon Baraliakos;Joachim Listing;Jan Brandt;Angela Zink

  • Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

    X Baraliakos;J Listing;M Rudwaleit;H Haibel

Frequent Co-Authors

Robert Landewé
Robert Landewé University of Amsterdam
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Joachim Sieper
Joachim Sieper Charité - University Medicine Berlin
Jürgen Braun
Jürgen Braun Rheumazentrum Ruhrgebiet
Maxime Dougados
Maxime Dougados Hôpital Cochin
Joachim Listing
Joachim Listing Leibniz Institute for Neurobiology
Walter P. Maksymowych
Walter P. Maksymowych University of Alberta
Mikkel Østergaard
Mikkel Østergaard University of Copenhagen
Filip Van den Bosch
Filip Van den Bosch Ghent University
Laure Gossec
Laure Gossec Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in alternative paths to entering or advancing in medicine? Flexible online programs can help you meet your career goals, especially if you’re balancing education with work or family responsibilities.

For nurses holding an associate degree, exploring rn to bsn programs no clinicals can be an efficient way to earn your Bachelor of Science in Nursing without on-site clinical requirements. This speeds up the process and increases accessibility for working professionals.

Those seeking the highest level of practice nursing may consider the fastest dnp online program to accelerate career advancement. Choosing the shortest dnp program can reduce study time, helping you achieve doctorate-level qualifications on a quicker timeline.

If your goal is to enter nursing quickly, enrolling in a 6 month lpn program online offers a fast-track route into practical nursing, allowing you to start caring for patients sooner.

These flexible, online pathways can help you adapt your education to your lifestyle and move forward in the rewarding field of health care.

Best Scientists Citing Xenofon Baraliakos

Trending Scientists

Recently Published Articles